REGENEREX PHARMA, INC — Revenue by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/dd0a5db2-d5ca-4119-b35f-24d15fa47965/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2020 | $1.8k | 2020-04-01 – 2021-03-31 | evidence 0001472375-21-000044 |
| FY 2019 | $2.6k | 2019-04-01 – 2020-03-31 | evidence 0001472375-20-000033 |
| FY 2014 | $9.2k | 2010-06-26 – 2014-08-31 | evidence 0001472375-14-000279 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
REGENEREX PHARMA, INC — all facts · Net Income · Operating Income